InternationalUSRemember you can easily switch between MIP US and MIP International at any time

How to make open innovation work



James Nurton


No fewer than four reports addressing open innovation have landed in my Inbox in the past couple of weeks. Is this just a coincidence, or is there a trend?

future Is OpenThe four reports are:

The Future is Open: 2015 State of Innovation (Thomson Reuters) – looking at how companies such as Samsung and Toyota have embraced open innovation (right)

Innovation without borders: Six best practices to improve innovation success rates (Evalueserve) – including case studies of companies such as P&G, Clorox and Danone (below left)

Executing an open innovation model (Deloitte) – focusing on the biopharma industry

Who Owns the World’s Patents? (ORoPO) – concluding that lack of transparency about patent ownership impedes IP licensing (below right)

EvaueserveThe Thomson Reuters report argues that there is indeed a trend towards collaboration, driven by the pace of innovation globally: "By leveraging that which has been done before and partnering with organizations that may solve for one aspect of an invention, companies are able to go to market more quickly and meet consumer demand for faster innovation time cycles." For example, about 130 of every 10,000 patents filed by are done jointly with an academic institution, and it ranks among the top 25 innovators in nine of the 12 industries analysed.

But open innovation is not new, of course, and the Evalueserve report identifies best practices based on experiences of companies such as Unilever and Nestlé. These include setting up dedicated teams, building innovation networks and developing an organisational culture to support innovation. P&G’s Connect & Develop programme is an oft-cited open innovation success story: innovation from external sources jumped from 10% to more than 50% from 2001 to 2008, and gave us products such as Tide Pods and Crest White Strips.

Deloitte’s report argues that biopharma companies, where a "closed, traditional model" accounts for about 80% of products, might learn from other industries where collaboration is more common. In fact, its analysis found that open innovation products enjoyed a higher success rate than closed-model products – but mentioned concerns about IP rights as one brake on further take-up. "For biopharma companies, OI seems to be the way forward, as it appears to be a more cost- and time-effective way to bring drugs to market. In fact, several key trends will likely continue to drive the adoption of OI, especially at the most open end of the spectrum," writes the report’s author, Ralph Marcello.

OROPOSo is open innovation now set to soar across diverse industries? The final report mentioned above provides a note of caution: "Given the historic trend in licensing, is that a great deal more value could be realised, if inefficiencies and uncertainties in the system could be eliminated – by solving the problem of patent ownership data accuracy." ORoPO is aiming to tackle this perceived problem by creating a global database of patent ownership, and already has some large IP owners on board.

One point that comes across in all of these reports is that effective open innovation requires engagement across an organisation, including the senior management, research, marketing and of course legal teams. Given the role played by patents and other IP rights, the involvement of the IP team is crucial, but are IP advisers (both in-house and outside) willing and able to make open innovation work, or are they still more comfortable following more traditional closed models? And, assuming your organisation wants to promote open innovation, what role should IP advisers play in implementing and developing it?

These are some questions that we will be coming back to over the next few months, and look forward to hearing readers’ views.

Comments






profile

Managing IP

ManagingIP

ManagingIP profile

Interesting law firm news: London IP boutique Redd to merge with @WigginLLP next month - full story https://t.co/Ko4ZmrT9aT

Oct 23 2017 09:01 ·  reply ·  retweet ·  favourite
ManagingIP profile

Rich pickings: how Hollywood rivals will profit from Weinstein's downfall https://t.co/3v4ZamycWP Analysis of Weinstein Co IP via @guardian

Oct 20 2017 03:32 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @BakerMcK_LonIP: Read @BakerIPnewsDACH and @BakerMcK_LonIP summary in @ManagingIP on the BGH's #3D chocolate packaging decision 🍫🇩🇪🇬🇧htt…

Oct 20 2017 02:28 ·  reply ·  retweet ·  favourite

Popular Posts

Blog Archive

IP-related blogs

1709 Copyright Blog

Afro-IP

AIA blog

Art and Artifice

China IPR

Class 99

Domain Incite

FOSS Patents

Green Patent Blog

Incontestable

IP CloseUp

IP Dragon

IP finance

IP Kat

IP Komodo

IP tango

IP Watchdog

IPEG

MARQUES Class 46

Orange Book Blog

Patent Baristas

PatentlyO

PatLit

SPC Blog

Spicy IP

The Trademark Blog

The TTABlog